
MALI Platform
AI Stock Research
Rubric Capital Management LP: latest 13F holdings
For the quarter ending 30 September 2026, Rubric Capital Management LP reported 89 positions worth $10.6B in total, filed with the SEC on 16 November 2026. The quarter before, it reported $10.9B.
Read the filing at SEC EDGARChecked: the cover page's entry count and total value match the holdings table.
Top 50 positions by value
| # | Issuer | Class | Value | Weight | Shares | vs quarter before |
|---|---|---|---|---|---|---|
| 1 | TALEN ENERGY CORP | COM | $1.1B | 10.58% | 3,602,171 | Unchanged |
| 2 | FTAI AVIATION LTD | SHS | $701.5M | 6.59% | 4,200,000 | Added 40.0% |
| 3 | VIATRIS INC | COM | $637.9M | 5.99% | 36,000,000 | Added 5.4% |
| 4 | TEVA PHARMACEUTICAL INDS LTD | SHS | $458.4M | 4.30% | 11,575,000 | New |
| 5 | GOLAR LNG LTD | SHS | $437.6M | 4.11% | 9,208,911 | Added 0.3% |
| 6 | GILDAN ACTIVEWEAR INC | COM | $397.6M | 3.73% | 9,327,914 | Added 107.3% |
| 7 | BGC GROUP INC | CL A | $303.2M | 2.85% | 26,295,028 | Added 10.5% |
| 8 | GDS HLDGS LTD | SPONSORED ADS | $278.4M | 2.61% | 8,913,999 | Added 1734.6% |
| 9 | ROIVANT SCIENCES LTD | SHS | $273.6M | 2.57% | 7,481,524 | Added 24.7% |
| 10 | VISTRA CORP | COM | $265.5M | 2.49% | 1,919,369 | Added 6.9% |
| 11 | TRANSALTA CORP | COM | $253.7M | 2.38% | 21,000,000 | Added 3.8% |
| 12 | ARCUTIS BIOTHERAPEUTICS INC | COM | $222.6M | 2.09% | 8,421,577 | Added 1.8% |
| 13 | KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | $209.9M | 1.97% | 2,813,469 | Cut 29.7% |
| 14 | DELEK US HLDGS INC NEW | COM | $191.8M | 1.80% | 2,687,449 | Unchanged |
| 15 | ZYMEWORKS INC | COM | $185.4M | 1.74% | 7,000,000 | Unchanged |
| 16 | AMCOR PLC | COM NEW | $180.0M | 1.69% | 4,300,000 | Added 3.3% |
| 17 | AMNEAL PHARMACEUTICALS INC | COM STK CL A | $171.9M | 1.61% | 8,536,755 | Cut 16.0% |
| 18 | CIMPRESS PLC | SHS EURO | $160.0M | 1.50% | 2,075,000 | Added 18.6% |
| 19 | GEO GROUP INC | COM | $158.1M | 1.48% | 5,187,353 | Added 25.6% |
| 20 | PENNYMAC FINL SVCS INC NEW | COM | $148.1M | 1.39% | 2,400,000 | Added 41.2% |
| 21 | ECHOSTAR CORP | CL A | $147.4M | 1.38% | 1,648,611 | New |
| 22 | INDIVIOR PHARMACEUTICALS INC | COM | $138.5M | 1.30% | 3,862,989 | New |
| 23 | CORECIVIC INC | COM | $130.0M | 1.22% | 4,030,385 | Added 41.5% |
| 24 | ADMA BIOLOGICS INC | COM | $123.9M | 1.16% | 12,352,584 | Added 32.3% |
| 25 | LIBERTY GLOBAL LTD | COM CL A | $121.2M | 1.14% | 13,278,653 | Added 13.0% |
| 26 | INTEGRA LIFESCIENCES HLDGS C | COM NEW | $119.7M | 1.12% | 7,353,934 | Cut 5.2% |
| 27 | FLUOR CORP | COM | $118.3M | 1.11% | 2,469,762 | Cut 50.8% |
| 28 | NURIX THERAPEUTICS INC | COM | $117.8M | 1.11% | 4,966,827 | Cut 31.3% |
| 29 | LIBERTY LATIN AMERICA LTD | COM CL C | $116.3M | 1.09% | 14,145,430 | Cut 9.6% |
| 30 | MANNKIND CORP | COM NEW | $114.8M | 1.08% | 29,430,000 | Added 63.5% |
| 31 | ALVOTECH | ORDINARY SHARES | $114.6M | 1.08% | 19,761,339 | Added 26.1% |
| 32 | APTIV PLC | COM SHS | $114.1M | 1.07% | 2,651,364 | New |
| 33 | CORE SCIENTIFIC INC NEW | COM | $111.9M | 1.05% | 7,000,000 | New |
| 34 | LIBERTY GLOBAL LTD | COM CL C | $99.6M | 0.94% | 11,201,830 | Added 21.0% |
| 35 | ENOVIS CORPORATION | COM | $96.8M | 0.91% | 5,300,000 | Added 35.9% |
| 36 | EDGEWELL PERSONAL CARE CO | COM | $94.6M | 0.89% | 3,504,525 | Cut 1.1% |
| 37 | MEIRAGTX HLDGS PLC | COM | $92.7M | 0.87% | 8,427,279 | Cut 7.4% |
| 38 | GALAXY DIGITAL INC. | CL A | $91.0M | 0.85% | 4,000,000 | Added 70.7% |
| 39 | NEWELL BRANDS INC | COM | $87.1M | 0.82% | 16,500,000 | Added 3.1% |
| 40 | ECOVYST INC | COM | $85.6M | 0.80% | 8,711,888 | Added 6.1% |
| 41 | MISSION PRODUCE INC | COM | $78.4M | 0.74% | 5,981,953 | Unchanged |
| 42 | OPKO HEALTH INC | COM | $76.9M | 0.72% | 47,791,243 | Unchanged |
| 43 | RENEW ENERGY GLOBAL PLC | CL A SHS | $75.2M | 0.71% | 11,000,000 | Unchanged |
| 44 | SUPERNUS PHARMACEUTICALS | COM | $74.9M | 0.70% | 1,739,892 | New |
| 45 | COMPASS INC | CL A | $73.0M | 0.69% | 8,218,394 | Unchanged |
| 46 | VENTURE GLOBAL INC | COM CL A | $68.4M | 0.64% | 5,410,280 | Unchanged |
| 47 | STRATASYS LTD | SHS | $67.7M | 0.64% | 8,150,000 | Added 1.9% |
| 48 | BIOHAVEN LTD | COM | $65.1M | 0.61% | 4,875,000 | Added 183.2% |
| 49 | SIX FLAGS ENTERTAINMENT CORP | COM | $63.7M | 0.60% | 5,944,841 | New |
| 50 | SCHRODINGER INC | COM | $61.5M | 0.58% | 1,980,830 | Cut 69.0% |
Showing the largest 50 of 89 positions. Every position is in MALI's SEC Financials & 13F workspace.
New this quarter
- TEVA PHARMACEUTICAL INDS LTD · $458.4M
- ECHOSTAR CORP · $147.4M
- INDIVIOR PHARMACEUTICALS INC · $138.5M
- APTIV PLC · $114.1M
- CORE SCIENTIFIC INC NEW · $111.9M
- SUPERNUS PHARMACEUTICALS · $74.9M
- SIX FLAGS ENTERTAINMENT CORP · $63.7M
Sold out
- TEVA PHARMACEUTICAL INDS LTD · was $527.7M
- ZOOM COMMUNICATIONS INC · was $238.7M
- AMAZON COM INC · was $214.5M
- MERCURY GENL CORP NEW · was $164.3M
- TREVI THERAPEUTICS INC · was $46.7M
- TRIPADVISOR INC · was $33.4M
- ANI PHARMACEUTICALS INC · was $21.4M
- UNIQURE NV · was $18.8M
- PROTO LABS INC · was $8.9M
- GRUPO AEROMEXICO SAB DE CV · was $8.4M
Reading a 13F
A 13F lists a manager's long positions in US-listed securities at the end of a quarter, filed up to 45 days later. It leaves out short positions, cash and most non-US holdings, so it is a partial, delayed view of a portfolio. Nothing here is investment advice.
Positions are named as the manager filed them. Values are the filing's own, in US dollars; changes compare share counts with the quarter before.